MedPath

Does a four week telerehabilitation program improve exercise capacity compared to receiving usual medical care in people who have persistent symptoms consistent with a previous COVID-19 infection?

Not Applicable
Active, not recruiting
Conditions
Post COVID-19
Infection - Other infectious diseases
Registration Number
ACTRN12622000355774
Lead Sponsor
Sydney Local Health District
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

1. People diagnosed with COVID-19 who were hospitalised due to the severity of their COVID-19 infection and who attend a Post-COVID Respiratory Clinic at RPAH or Concord Hospital or people diagnosed with COVID-19 and who were managed in the community, either at home or by virtual care.
2. Ongoing symptoms consistent with post-COVID sequelae
3. Sex: All genders
4. Age range: greater than or equal to 18 years old
5. Identified by treating physician as suitable for rehabilitation
6. Willingness to provide informed consent and willingness to participate and comply with the study requirements.

Exclusion Criteria

1.People with severe COVID-19 requiring long stay ICU who develop post-ICU syndrome. These people need rehabilitation and therefore should not be in a RCT in which they may be randomised to no rehabilitation.
2.People with acute symptoms of any illness where exercise is not recommended
3.People who are not medically stable as judged by treating physician
4.Women who are pregnant or post-partum
5. No access to appropriate technology (e.g internet, computer or tablet)
6. Difficulty understanding English and unable to access an interpreter
7. Severe cognitive impairment or other comorbidities which would make exercise unsafe, as assessed by the referring physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Functional exercise capacity measured by the 1-minute sit-to-stand test. [ Prior to and at the completion of the 4 week intervention or control period and at 12-month follow-up]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath